imaging system ivis spectrum Search Results


94
Revvity ivis imaging system
Ivis Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/10__1039_slash_c7sc04853j-310-9-13?v=Revvity
Average 94 stars, based on 1 article reviews
ivis imaging system - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

96
Revvity ivis system
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Ivis System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/bio_rxiv__64898__2026__04__16__719092-161-17-19?v=Revvity
Average 96 stars, based on 1 article reviews
ivis system - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

90
BIOSPACE LAB ivis spectrum imaging system photon imagertm optima
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Ivis Spectrum Imaging System Photon Imagertm Optima, supplied by BIOSPACE LAB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/pm39625467__ja4c12531_si_001-73-23-30?v=BIOSPACE+LAB
Average 90 stars, based on 1 article reviews
ivis spectrum imaging system photon imagertm optima - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
FUJIFILM VisualSonics Inc ivis spectrum in vivo imaging system
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Ivis Spectrum In Vivo Imaging System, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/pm37620448-235-22-29?v=FUJIFILM+VisualSonics+Inc
Average 90 stars, based on 1 article reviews
ivis spectrum in vivo imaging system - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Vilber Lourmat ivis spectrum imaging system
(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by <t>IVIS</t> imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Ivis Spectrum Imaging System, supplied by Vilber Lourmat, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/pm38741170-168-16-20?v=Vilber+Lourmat
Average 90 stars, based on 1 article reviews
ivis spectrum imaging system - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Caliper Life Sciences ivis spectrum
High metastatic tumor EVs induce tumor cell adhesion to the lung and promote lung metastasis. (A) The experimental design of tumor EV and tumor cell injection. Tumor cells were injected after five injections of A375SM-EVs. After 24 h and 40 days, tumor cell signals were analyzed using an in vivo imaging system <t>(IVIS).</t> (B, C) Tumor cell luminescence intensity in the lungs of the control and A375SM-EV injected groups was detected using IVIS Spectrum 24 h after tumor injection (B) . Quantitative analysis of luminescence intensity (Total flux) was shown in (C) (**P = 0.012, Wilcoxon test; n = 5 mice per group). (D) Tumor cell luminescence intensity in the control and A375SM-EV injected groups after 40 days from tumor injection was detected using IVIS Spectrum. Quantitative analysis of luminescence intensity (Total flux) was shown in (E) (**P = 0.037, Wilcoxon test; n = 5 mice per group). (F) Representative H-E staining images of lung metastases in the two groups. Arrows indicate tumor nodules. (G) The number of metastatic nodules in the whole lung tissue was quantified (**P = 0.026, Wilcoxon test; n = 5 mice per group).
Ivis Spectrum, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/pmc10130374-119-20-22?v=Caliper+Life+Sciences
Average 86 stars, based on 1 article reviews
ivis spectrum - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Guangzhou Biolight Biotechnology Co Ltd ivis spectrum imaging system
High metastatic tumor EVs induce tumor cell adhesion to the lung and promote lung metastasis. (A) The experimental design of tumor EV and tumor cell injection. Tumor cells were injected after five injections of A375SM-EVs. After 24 h and 40 days, tumor cell signals were analyzed using an in vivo imaging system <t>(IVIS).</t> (B, C) Tumor cell luminescence intensity in the lungs of the control and A375SM-EV injected groups was detected using IVIS Spectrum 24 h after tumor injection (B) . Quantitative analysis of luminescence intensity (Total flux) was shown in (C) (**P = 0.012, Wilcoxon test; n = 5 mice per group). (D) Tumor cell luminescence intensity in the control and A375SM-EV injected groups after 40 days from tumor injection was detected using IVIS Spectrum. Quantitative analysis of luminescence intensity (Total flux) was shown in (E) (**P = 0.037, Wilcoxon test; n = 5 mice per group). (F) Representative H-E staining images of lung metastases in the two groups. Arrows indicate tumor nodules. (G) The number of metastatic nodules in the whole lung tissue was quantified (**P = 0.026, Wilcoxon test; n = 5 mice per group).
Ivis Spectrum Imaging System, supplied by Guangzhou Biolight Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/pm41950927-342-6-10?v=Guangzhou+Biolight+Biotechnology+Co+Ltd
Average 86 stars, based on 1 article reviews
ivis spectrum imaging system - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Spectrum Analytic Inc ivis spectrum analytical 'image math' tool
High metastatic tumor EVs induce tumor cell adhesion to the lung and promote lung metastasis. (A) The experimental design of tumor EV and tumor cell injection. Tumor cells were injected after five injections of A375SM-EVs. After 24 h and 40 days, tumor cell signals were analyzed using an in vivo imaging system <t>(IVIS).</t> (B, C) Tumor cell luminescence intensity in the lungs of the control and A375SM-EV injected groups was detected using IVIS Spectrum 24 h after tumor injection (B) . Quantitative analysis of luminescence intensity (Total flux) was shown in (C) (**P = 0.012, Wilcoxon test; n = 5 mice per group). (D) Tumor cell luminescence intensity in the control and A375SM-EV injected groups after 40 days from tumor injection was detected using IVIS Spectrum. Quantitative analysis of luminescence intensity (Total flux) was shown in (E) (**P = 0.037, Wilcoxon test; n = 5 mice per group). (F) Representative H-E staining images of lung metastases in the two groups. Arrows indicate tumor nodules. (G) The number of metastatic nodules in the whole lung tissue was quantified (**P = 0.026, Wilcoxon test; n = 5 mice per group).
Ivis Spectrum Analytical 'Image Math' Tool, supplied by Spectrum Analytic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/pm24941427-100-27-23?v=Spectrum+Analytic+Inc
Average 90 stars, based on 1 article reviews
ivis spectrum analytical 'image math' tool - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
VILBER GmbH ivis spectrum imaging system
High metastatic tumor EVs induce tumor cell adhesion to the lung and promote lung metastasis. (A) The experimental design of tumor EV and tumor cell injection. Tumor cells were injected after five injections of A375SM-EVs. After 24 h and 40 days, tumor cell signals were analyzed using an in vivo imaging system <t>(IVIS).</t> (B, C) Tumor cell luminescence intensity in the lungs of the control and A375SM-EV injected groups was detected using IVIS Spectrum 24 h after tumor injection (B) . Quantitative analysis of luminescence intensity (Total flux) was shown in (C) (**P = 0.012, Wilcoxon test; n = 5 mice per group). (D) Tumor cell luminescence intensity in the control and A375SM-EV injected groups after 40 days from tumor injection was detected using IVIS Spectrum. Quantitative analysis of luminescence intensity (Total flux) was shown in (E) (**P = 0.037, Wilcoxon test; n = 5 mice per group). (F) Representative H-E staining images of lung metastases in the two groups. Arrows indicate tumor nodules. (G) The number of metastatic nodules in the whole lung tissue was quantified (**P = 0.026, Wilcoxon test; n = 5 mice per group).
Ivis Spectrum Imaging System, supplied by VILBER GmbH, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/pmc11089771-170-16-20?v=VILBER+GmbH
Average 86 stars, based on 1 article reviews
ivis spectrum imaging system - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Caliper Life Sciences vitro imaging system ivis spectrum system
High metastatic tumor EVs induce tumor cell adhesion to the lung and promote lung metastasis. (A) The experimental design of tumor EV and tumor cell injection. Tumor cells were injected after five injections of A375SM-EVs. After 24 h and 40 days, tumor cell signals were analyzed using an in vivo imaging system <t>(IVIS).</t> (B, C) Tumor cell luminescence intensity in the lungs of the control and A375SM-EV injected groups was detected using IVIS Spectrum 24 h after tumor injection (B) . Quantitative analysis of luminescence intensity (Total flux) was shown in (C) (**P = 0.012, Wilcoxon test; n = 5 mice per group). (D) Tumor cell luminescence intensity in the control and A375SM-EV injected groups after 40 days from tumor injection was detected using IVIS Spectrum. Quantitative analysis of luminescence intensity (Total flux) was shown in (E) (**P = 0.037, Wilcoxon test; n = 5 mice per group). (F) Representative H-E staining images of lung metastases in the two groups. Arrows indicate tumor nodules. (G) The number of metastatic nodules in the whole lung tissue was quantified (**P = 0.026, Wilcoxon test; n = 5 mice per group).
Vitro Imaging System Ivis Spectrum System, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imaging+system+ivis+spectrum/pm24677375-97-7-13?v=Caliper+Life+Sciences
Average 86 stars, based on 1 article reviews
vitro imaging system ivis spectrum system - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


(a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by IVIS imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: bioRxiv

Article Title: Coordinated Tuning of Ionizable Lipids and Formulation Redirects mRNA Vaccines Toward Lymphoid-Specific CD4 + T Cell Immunity

doi: 10.64898/2026.04.16.719092

Figure Lengend Snippet: (a) Experimental scheme for in vivo screening. C57BL/6N mice were intramuscularly administered fLuc mRNA-loaded LNPs (0.05 mg/kg) and bioluminescence was assessed at 6 h post-injection by IVIS imaging. (b) Representative in vivo IVIS bioluminescence images of nine LNP formulations. (c) Quantification of bioluminescence signals at the injection site. (d) Quantification of bioluminescence signals in the liver. (e) Injection site-to-liver bioluminescence ratio (n = 2 per group). N4Y and N4Z were selected as lead candidates based on high injection site expression and minimal hepatic off-target signal. (f, g) Time-dependent serum levels of MCP-1 (f) and IL-6 (g) following intramuscular administration of N4Y- or N4Z-based LNPs encapsulating SARS-CoV-2 spike mRNA (0.5 mg/kg) in BALB/c mice (n = 4 per group). Statistical significance was determined by unpaired two-tailed Student’s t-test at each time point. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: Luciferase expression was assessed by whole-body bioluminescence imaging and ex vivo imaging of harvested organs using an IVIS system (PerkinElmer).

Techniques: In Vivo, Injection, Imaging, Expressing, Two Tailed Test

(a) Schematic comparison of lipid compositions of N4Z and optimized N4Z (N4Z-opt) formulations. (b) mRNA encapsulation efficiency (n = 3). (c) Hydrodynamic diameter (n = 3). (d) Polydispersity index (PDI) (n = 3). (e) Representative flow cytometry contour plots showing GFP expression in RAW 264.7 macrophages following delivery of PBS, N4Z, and N4Z-opt. (f) Mean fluorescence intensity (MFI) of GFP expression in RAW 264.7 macrophages (n = 3). (g) Representative in vivo IVIS bioluminescence images following intramuscular administration of fLuc mRNA-loaded N4Z or N4Z-opt LNPs. (h) Injection site-to-body bioluminescence ratio (n = 3). (i) Representative ex vivo organ images showing bioluminescence in liver, spleen, and lymph node. (j) Spleen-to-liver bioluminescence ratio (n = 3). (k) Lymph node-to-liver bioluminescence ratio (n = 3). Statistical significance for (b–d) was determined by unpaired two-tailed Student’s t -test. Statistical significance for (f, h, j, k) was determined by one-way ANOVA followed by Tukey’s multiple comparisons test. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: bioRxiv

Article Title: Coordinated Tuning of Ionizable Lipids and Formulation Redirects mRNA Vaccines Toward Lymphoid-Specific CD4 + T Cell Immunity

doi: 10.64898/2026.04.16.719092

Figure Lengend Snippet: (a) Schematic comparison of lipid compositions of N4Z and optimized N4Z (N4Z-opt) formulations. (b) mRNA encapsulation efficiency (n = 3). (c) Hydrodynamic diameter (n = 3). (d) Polydispersity index (PDI) (n = 3). (e) Representative flow cytometry contour plots showing GFP expression in RAW 264.7 macrophages following delivery of PBS, N4Z, and N4Z-opt. (f) Mean fluorescence intensity (MFI) of GFP expression in RAW 264.7 macrophages (n = 3). (g) Representative in vivo IVIS bioluminescence images following intramuscular administration of fLuc mRNA-loaded N4Z or N4Z-opt LNPs. (h) Injection site-to-body bioluminescence ratio (n = 3). (i) Representative ex vivo organ images showing bioluminescence in liver, spleen, and lymph node. (j) Spleen-to-liver bioluminescence ratio (n = 3). (k) Lymph node-to-liver bioluminescence ratio (n = 3). Statistical significance for (b–d) was determined by unpaired two-tailed Student’s t -test. Statistical significance for (f, h, j, k) was determined by one-way ANOVA followed by Tukey’s multiple comparisons test. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Luciferase expression was assessed by whole-body bioluminescence imaging and ex vivo imaging of harvested organs using an IVIS system (PerkinElmer).

Techniques: Comparison, Encapsulation, Flow Cytometry, Expressing, Fluorescence, In Vivo, Injection, Ex Vivo, Two Tailed Test

High metastatic tumor EVs induce tumor cell adhesion to the lung and promote lung metastasis. (A) The experimental design of tumor EV and tumor cell injection. Tumor cells were injected after five injections of A375SM-EVs. After 24 h and 40 days, tumor cell signals were analyzed using an in vivo imaging system (IVIS). (B, C) Tumor cell luminescence intensity in the lungs of the control and A375SM-EV injected groups was detected using IVIS Spectrum 24 h after tumor injection (B) . Quantitative analysis of luminescence intensity (Total flux) was shown in (C) (**P = 0.012, Wilcoxon test; n = 5 mice per group). (D) Tumor cell luminescence intensity in the control and A375SM-EV injected groups after 40 days from tumor injection was detected using IVIS Spectrum. Quantitative analysis of luminescence intensity (Total flux) was shown in (E) (**P = 0.037, Wilcoxon test; n = 5 mice per group). (F) Representative H-E staining images of lung metastases in the two groups. Arrows indicate tumor nodules. (G) The number of metastatic nodules in the whole lung tissue was quantified (**P = 0.026, Wilcoxon test; n = 5 mice per group).

Journal: Frontiers in Oncology

Article Title: miR-1246 in tumor extracellular vesicles promotes metastasis via increased tumor cell adhesion and endothelial cell barrier destruction

doi: 10.3389/fonc.2023.973871

Figure Lengend Snippet: High metastatic tumor EVs induce tumor cell adhesion to the lung and promote lung metastasis. (A) The experimental design of tumor EV and tumor cell injection. Tumor cells were injected after five injections of A375SM-EVs. After 24 h and 40 days, tumor cell signals were analyzed using an in vivo imaging system (IVIS). (B, C) Tumor cell luminescence intensity in the lungs of the control and A375SM-EV injected groups was detected using IVIS Spectrum 24 h after tumor injection (B) . Quantitative analysis of luminescence intensity (Total flux) was shown in (C) (**P = 0.012, Wilcoxon test; n = 5 mice per group). (D) Tumor cell luminescence intensity in the control and A375SM-EV injected groups after 40 days from tumor injection was detected using IVIS Spectrum. Quantitative analysis of luminescence intensity (Total flux) was shown in (E) (**P = 0.037, Wilcoxon test; n = 5 mice per group). (F) Representative H-E staining images of lung metastases in the two groups. Arrows indicate tumor nodules. (G) The number of metastatic nodules in the whole lung tissue was quantified (**P = 0.026, Wilcoxon test; n = 5 mice per group).

Article Snippet: After 24 h, VivoGlo Luciferin, In Vivo Grade (Promega), was intraperitoneally administered, and the tumor cell signals were detected using IVIS Spectrum (Caliper Life Sciences, Hopkinton, MA, USA) to analyze tumor cell adhesion to the lung.

Techniques: Injection, In Vivo Imaging, Control, Quantitative Luminescence, Staining

miR-1246 knockdown of tumor cells reduces lung metastasis. (A) Images of mice, 28 days after subcutaneous injection of Control-miR A375SM and Anti-miR-1246 A375SM. (B) miR-1246 levels in serum EVs from Control-miR A375SM or Anti-miR-1246 A375SM tumor-bearing mice. Sera were collected 28 days after subcutaneous injection of each tumor (**P = 0.037, Wilcoxon test; data are presented as mean ± SD; n = 3 real-time RT-PCR runs, n = 5 mice per group). (C) Tumor volume was assessed using the formula: (width 2 × length)/2 (mm 3 ). Two-sided Student’s t-test. N.S.: not significant. P = 0.42 (D) Tumor cell fluorescence intensity (GFP signal) in the lungs was detected using IVIS Spectrum. Quantitative analysis of fluorescence intensity (Total flux) was shown in (E) (**P = 0.022, Wilcoxon test; n = 5 mice per group).

Journal: Frontiers in Oncology

Article Title: miR-1246 in tumor extracellular vesicles promotes metastasis via increased tumor cell adhesion and endothelial cell barrier destruction

doi: 10.3389/fonc.2023.973871

Figure Lengend Snippet: miR-1246 knockdown of tumor cells reduces lung metastasis. (A) Images of mice, 28 days after subcutaneous injection of Control-miR A375SM and Anti-miR-1246 A375SM. (B) miR-1246 levels in serum EVs from Control-miR A375SM or Anti-miR-1246 A375SM tumor-bearing mice. Sera were collected 28 days after subcutaneous injection of each tumor (**P = 0.037, Wilcoxon test; data are presented as mean ± SD; n = 3 real-time RT-PCR runs, n = 5 mice per group). (C) Tumor volume was assessed using the formula: (width 2 × length)/2 (mm 3 ). Two-sided Student’s t-test. N.S.: not significant. P = 0.42 (D) Tumor cell fluorescence intensity (GFP signal) in the lungs was detected using IVIS Spectrum. Quantitative analysis of fluorescence intensity (Total flux) was shown in (E) (**P = 0.022, Wilcoxon test; n = 5 mice per group).

Article Snippet: After 24 h, VivoGlo Luciferin, In Vivo Grade (Promega), was intraperitoneally administered, and the tumor cell signals were detected using IVIS Spectrum (Caliper Life Sciences, Hopkinton, MA, USA) to analyze tumor cell adhesion to the lung.

Techniques: Knockdown, Injection, Control, Quantitative RT-PCR, Fluorescence